EVLO (Evelo Biosciences) Stock Based Compensation: $11.17 Mil (TTM As of Sep. 2023)


What is Evelo Biosciences Stock Based Compensation?

Evelo Biosciences EVLO -99.00% Stock Based Compensation is $11.17 Mil as of Sep. 2023.

Evelo Biosciences's Stock Based Compensation for the three months ended in Sep. 2023 was $2.48 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 was $11.17 Mil.

Evelo Biosciences Stock Based Compensation Related Terms

Evelo Biosciences Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Stock Based Compensation Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
Get a 7-Day Free Trial 6.06 8.17 8.47 15.85 15.16

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.46 3.42 2.91 2.37 2.48

Evelo Biosciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.17 Mil.

What does a Stock Based Compensation of $11.17 Mil mean?
Evelo Biosciences (EVLO) has a Stock Based Compensation of $11.17 Mil as of Sep. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Evelo Biosciences and its competitors.
Is Evelo Biosciences' Stock Based Compensation too high?
Evelo Biosciences' current Stock Based Compensation is $11.17 Mil.
How does Evelo Biosciences' Stock Based Compensation compare to IMNN and EDSA?
Evelo Biosciences' Stock Based Compensation of $11.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Evelo Biosciences and its competitors. Evelo Biosciences's current Stock Based Compensation is $11.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Stock Based Compensation of $11.17 Mil. The current Stock Based Compensation is $11.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Stock Based Compensation is $11.17 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.